Why Catalent? Fast, Flexible, Proven Solutions: Catalent is the global leader in drug development. By utilizing our robust network of expertise and innovative technologies, Catalent offers the most comprehensive solutions from early-phase development to commercial manufacturing.
NEWS. Catalent to Present on Integrated UpTempo℠ Gene Therapy Development Platform at Upcoming ASGCT Annual Meeting; Catalent and Bhami Research Laboratory Enter into Licensing Agreement for Technology to Deliver High-Concentration Biologics Subcutaneously
Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people,[3] including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.[1]
Wikipedia
Official Website